Stock DHT HA TAY PHARMACEUTICAL
Add to a list
To use this feature you must be a member
Log inSign up

News Ha Tay Pharmaceutical

Equities

DHT

VN000000DHT3

End-of-day quote HANOI S.E.
Other stock markets
 18:00:00 2024-06-03 EDT 		5-day change 1st Jan Change
42,100 VND -0.94% Intraday chart for Ha Tay Pharmaceutical +7.12% +83.04%
04-25 Ha Tay Pharmaceutical JSC Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
01-22 Ha Tay Pharmaceutical JSC Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Ha Tay Pharmaceutical JSC Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Ha Tay Pharmaceutical JSC Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Ha Tay Pharmaceutical JSC announced that it has received VND 180.6 billion in funding from ASKA Pharmaceutical Holdings Co.,Ltd.
CI
Ha Tay Pharmaceutical JSC Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Ha Tay Pharmaceutical JSC Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Ha Tay Pharmaceutical JSC Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Ha Tay Pharmaceutical JSC Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Ha Tay Pharmaceutical JSC Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Ha Tay Pharmaceutical JSC Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Ha Tay Pharmaceutical JSC Reports Earnings Results for the Fourth Quarter Ended December 31, 2021
CI
Ha Tay Pharmaceutical JSC Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Ha Tay Pharmaceutical JSC Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
Ha Tay Pharmaceutical Jsc Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
Ha Tay Pharmaceutical Jsc Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
ASKA Pharmaceutical Co., Ltd. acquired additional 20% stake in Ha Tay Pharmaceutical JSC.
CI
ASKA Pharmaceutical Co., Ltd. completed the acquisition of 24.9% stake in Ha Tay Pharmaceutical JSC.
CI
Ha Tay Pharmaceutical JSC announced that it has received VND 369.70241 billion in funding from ASKA Pharmaceutical Co., Ltd.
CI
Ha Tay Pharmaceutical Jsc Reports Earnings Results for the Third Quarter Ended September 30, 2020
CI
Ha Tay Pharmaceutical JSC announced that it expects to receive VND 369.70241 billion in funding from ASKA Pharmaceutical Co., Ltd. and other investors
CI
ASKA Pharmaceutical Co., Ltd. signed an agreement to acquire 24.9% stake in Ha Tay Pharmaceutical JSC.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DHT Stock
  4. News Ha Tay Pharmaceutical